Through the collaboration with PubGene, many of the Brain Tumor Association's members have gained access to their own CoreMine Vitae report as a supplement to their regular treatment. Brain tumor patients in Norway have no standardized tool for co-selection and decision support. Through the report, they have received advice on appropriate treatments that are tailored to their personal medical profile, based on their genetic profile and the disease. The report has thus contributed to empowering patients to make better decisions about treatment and opportunities for participation in clinical trials by facilitating better co-selection.
Through the collaboration with PubGene, many of the Brain Tumor Association's members have gained access to their own CoreMine Vitae report as a supplement to their regular treatment. Brain tumour patients in Norway do not have a standardized tool for co-selection and decision support.
Through the report, they have received advice on relevant treatments that are adapted to their personal medical profile, based on their genetic profile and the disease. The report has thus contributed to the patient being able to make better decisions about treatment and opportunities for participation in clinical trials, by facilitating better co-selection.
